A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA UCSD
- Dates
- study startedcompletion around
- Principal Investigator
- by Michael Wilkinson (ucsd)Jonathan Soverow (ucla)William French (ucla)Dianne Cheung (ucla)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientists at University of California Health
- Michael Wilkinson (ucsd)
Associate Clinical Professor, Medicine, Vc-health Sciences-schools. Authored (or co-authored) 18 research publications - Jonathan Soverow (ucla)
Hs Associate Clinical Professor, Medicine. Authored (or co-authored) 19 research publications - William French (ucla)
Adjunct Professor, Medicine. Authored (or co-authored) 98 research publications - Dianne Cheung (ucla)
HS Associate Clinical Professor, Medicine. Authored (or co-authored) 7 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Eli Lilly and Company
- Links
- Related Info
- ID
- NCT06292013
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 12500 study participants
- Last Updated